Paul Eliezer Oberstein MD

Oncology•New York, NY

Gastrointestinal Cancer, Hematologic Oncology

Director, GI Medical Oncology. Assistant Director, Pancreatic Cancer Center. NYU Perlmutter Cancer Center

Join to View Full Profile

240 East 38th Street20th FloorNew York, NY 10016

Education & Training

Columbia University Mailman School of Public HealthMS, Biostatistics, 2013 - 2015
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2010 - 2013
Temple University HospitalResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006

Certifications & Licensure

NY State Medical License 2010 - 2025
PA State Medical License 2006 - 2010
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient Oriented Research Scholarship Mailman School of Public Health, Columbia University, 2013-2015
Chief Fellow in Hematology/Oncology Columbia University Medical Center, 2012-2013

Clinical Trials

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Completed
Phase 2
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting Start of enrollment: 2014 Feb 05
Completed
Phase 2
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy Start of enrollment: 2014 Dec 16
Completed
Phase 3
A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma Start of enrollment: 2015 Mar 31
Completed
Phase 1, Phase 2
Collection and Storage of Tissue and Blood Samples From Patients With Cancer Start of enrollment: 2015 May 19
RECRUITING
Perioperative Chemo and Pembrolizumab in Gastric Cancer Start of enrollment: 2017 Nov 25
Completed
Phase 2
Azacitidine and Pembrolizumab in Pancreatic Cancer Start of enrollment: 2017 Oct 01
ACTIVE_NOT_RECRUITING
PHASE2
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer Start of enrollment: 2022 Nov 15
RECRUITING
NA
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE).
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, Dan G Duda, Robin Park
Future Oncology. 2025-03-28
Association of tumor microbiome with survival in resected early-stage PDAC.
Yixuan Meng, Chan Wang, Mykhaylo Usyk, Soyoung Kwak, Chengwei Peng
Msystems. 2025-03-18
Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model.
Philip J Chang, Andrew E Hendifar, Gillian Gresham, An Ngo-Huang, Paul E Oberstein
Cancers. 2025-02-13

Press Mentions

4 Troubling Cancer Trends You Must Know About in 2025March 17th, 2025
Cancer Rates Rise Among People Under Age 50August 18th, 2023
Report Shows Alarming Rise in Colorectal Cancer Rates Among US Adults Under 55March 2nd, 2023
Join now to see all

Grant Support

Pancreatic Cancer Action Network Translational Research GrantPancreatic Cancer Action Network2017–2019
KL2 Mentored Career Development AwardNIH2015–2017
Young Investigator AwardAmerican Society of Clinical Oncology2013–2014

Committees

Member, SWOG, GI Committee 2013 - Present
Member, Protocol Review and Monitoring Committee, Herbert Irving Comprehensive Cancer Center 2014 - 2018

Professional Memberships